Clinical significance of serum procalcitonin in patients with ulcerative colitis

Table 1 Baseline characteristics of patients with ulcerative colitis

	Mild-to-moderate1	Severe	P value
Age upon entry, yr (mean ± SD)	39.3 ± 12.5	40.0 ± 19.7	> 0.2
Gender, male/female	6/5	7/0	> 0.2
Extent of disease
Number of patients			> 0.2
Extensive	7	7
Left-side	4	0
Proctitis	0	0
Concomitant medication use
Number of patients			> 0.2
Sulfasalazine	3	0
5-ASA	9	7
Glucocorticoid	6	2
Immunomodulator	1	0

¹Severity assessments were based on Truelove and Witts’ severity index. Eighteen ulcerative colitis (UC) patients were included in the study. The distribution of age and sex was not significantly different between mild-to-moderate and severe UC. There was no difference in the extent of disease and concomitant medication use between mild-to-moderate and severe UC. ASA: 5-aminosalicylic acid.